baber/WOPTO huggingface dataset:
Patent CA-2621069-A1 (CA)
Inventor: STREATER JAMES R JR
IPC: E21B31/00
Filed: 2006-08-11
Abstract: Disclosed is an improved spear head overshot. The spear head overshot is particularly useful as part of a cable-guided fishing assembly. The spear head overshot essentially comprises one or more pivot lugs, the pivot lugs comprising jaw sections and release point sections, an actuator slide, a wave spring, a pivot mandrel, a screw attached to the pivot mandrel, and a compression spring threaded over the screw. In operation, a spear head is inserted into the spear head overshot until the spear head passes the jaw sections of the pivot lugs, at which time the spear head is locked into place.  To release the spear head, the release point sections of the pivot lugs are manually forced inward. Simultaneously, the jaw sections of the pivot lugs are forced outward, thereby allowing the spear head to be removed from the spear head overshot. In a cable-guided fishing operation, this process can be repeated as often as necessary.
Patent CA-2621328-A1 (CA)
Title: Gene encoding cell wall mannoprotein and use thereof
Inventor: OHMURA FUMIHIKO
IPC: A23L7/20
Filed: 2006-09-21
Abstract: The present invention relates to a brewer's yeast which produces alcoholic beverages having an ability for reducing the haze level, alcoholic beverages produced using such a yeast, and a method of producing such alcoholic beverages. More specifically, the present invention relates to a yeast which can reduce the level of haze in the product by increasing the level of expression of ScCWP2 gene encoding cell wall mannoprotein Cwp2p in brewer's yeast, or non-ScCWP2 gene characteristic to beer yeast, and to a method of producing alcoholic beverages using such a yeast.
Patent CA-2623593-A1 (CA)
Title: Improved process for analyzing, for separating, and for isolating individual polar protic monomers and/or oligomers
Inventor: KELM MARK A
IPC: B01D15/08
Filed: 2006-10-03
Abstract: A process for separating and isolating individual polar protic monomer(s) and/or oligomer(s) on the basis of degree of polymerization is disclosed. A  liquid sample containing monomer(s) and/or oligomer(s) is introduced into a liquid chromatography (LC) column packed with a polar bonded stationary chromatographic phase. The individual monomer(s) and/or oligomer(s) are separated via a binary mobile phase elution. The monomer(s) and/or oligomer(s) may be proanthocyanidins, hydrolyzable tannins, oligosaccharides, oligonucleotides, peptides, acrylamides, polysorbates, polyketides, poloxamers, polyethylene glycols, polyoxyethylene alcohols, or polyvinyl alcohols. The binary mobile phase comprises an A phase consisting essentially of a polar aprotic solvent and a B phase consisting essentially of a polar protic solvent. A process for separating and isolating xanthine(s) e.g., caffeine and theobromine is also disclosed. A liquid sample containing xanthine(s) and the monomer(s) and/or oligomer(s) is introduced into an LC  column packed with a polar bonded stationary chromatographic phase. The xanthines are separated via an isocratic mobile phase elution and the individual fraction(s) are eluted. A process for separating and isolating the xanthines as well as polar protic monomer(s) and/or oligomer(s) is also disclosed. The phases discussed above are used in this rocess.
Patent CA-2624765-A1 (CA)
Title: Wholly automated mobile device and corresponding fast, economical and compact method for parking private vehicles
Inventor: STUTZ FRIDOLIN
IPC: E04H6/28
Filed: 2005-10-12
Abstract: The invention concerns an automated device for parking private vehicles, comprising a modular dismountable construction consisting of one or more automatic parking ramps whereon the driver leaves his/her vehicle, the vehicle being then positioned, mechanically centered, gripped and electronically measured, automatically, so that the vehicle can be displaced by computer and compactly stored. Said device consists essentially of a push system (tractor, 40) moving on a rail (tractor rail, 42), gripping the vehicles at the wheels using forks with specific rollers (45), pulling same onto the lifting platform (31) in centered position on the rollers, moving the platform vertically, rotating the platform about its vertical axis and pushing the vehicle onto the parking platform (8). On request, the vehicles are once more pulled onto the lifting platform, transported to the exit ramp and delivered to the user. The entire device consists of a reduced number of mobile components such that the construction and the use of said device are simple and economical. The inventive device uses the basic shapes of modern vehicles combined with the inventive method and a computerized allocation of places enables the space required as well as building and use costs to be considerably reduced compared to existing systems.
Patent CA-2625016-A1 (CA)
Title: Hinged plow and scraper blade
Inventor: STEVENSON DONALD
IPC: E01H5/06
Filed: 2008-03-10
Abstract: A materials moving blade (1) comprising a main blade (3) having a materials engaging surface extending bounded by a first end, a second end, a top edge (37) and a lower edge (39) defining a hinge axis, a plurality of trip blades (9) supported at the lower edge (39) of the main blade(3) and a universal mounting panel having a plurality of holes in the mounting panel for accommodating different mounting system geometries.
Patent CA-2628224-A1 (CA)
Title: Vinyl-pyrrolidinone cephalosporins with basic substituents
Inventor: ANGEHRN PETER
IPC: C07D501/24
Filed: 1997-12-10
Abstract: The present invention relates to cephalosporin derivatives of the general formula   wherein X is CH or N;   R1 is hydrogen or cyclopentyl;   R2 is a group of formula   R3 is hydrogen, an alkalimetal ion or a tertiary ammonium group;     R4 is hydrogen, an amino protecting group, pyrrolidin-2-ylmethyl, azetidin-3-ylmethyl, iminomethyl, 1-carbamimidoyl;     R5 is hydrogen, dialkylcarbamoyl, co-hydroxyalkyl, .omega.-aminoalkyl, pyridinium-1-ylmethyl, 1-hydroxy-3-aminomethyl-propyl or (hydroxy)-(pyrrolidin-2-yl)methyl;   R6 is hydrogen, trifluoromethyl or hydroxy; and R7 is alkyl, .omega.-hydroxy-alkyl, cycloalkyl, 3-pyrrolidinyl, 3-azetidinyl, iminomethyl or 1-carbamimidoyl; as well as readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts; the invention is further concerned with the manufacture of compounds of formula I; with their use as pharmaceutically active substances, particularly for the treatment and prophylaxis of infectious diseases, and with pharmaceutical preparations containing a compound of formula I for the treatment and prophylaxis of infectious diseases.
Patent CA-2628499-A1 (CA)
Title: Method for the production of a hot-rolled steel strip and combined casting and rolling plant for carrying out the method
Inventor: MAIERL JOSEF
IPC: B21B1/46
Filed: 2006-11-03
Abstract: A method for producing a hot-rolled steel strip from a steel melt in a continuous production process, with the strip running through uninterruptedly, comprises the following method steps: continuous casting of a steel strand (5) in a continuous casting mould (2) of a continuous casting installation (1), roll forming of the cast steel strand in a first group of roll stands (6) to form a pre-rolled hot strip (7), further roll forming of the pre-rolled hot strip in a second group of roll stands (19) to form a hot-rolled steel strip (21), setting the pre-rolled hot strip to rolling temperature between the first group of roll stands and the second group of roll stands in a temperature setting device (14), and winding up the hot-rolled steel strip into coils or dividing up the hot-rolled steel strip into panels. In order to increase flexibility in the production of different grades of steel and keep investment costs and operating costs low, it is proposed that the pre-rolled hot strip is descaled immediately before entering the temperature setting device, the pre-rolled hot strip is kept in a protective gas atmosphere in the temperature setting device and the pre-rolled hot strip is roll-formed in the second group of roll stands immediately after running through the temperature setting device. Furthermore, a combined casting and rolling installation for carrying out the method is proposed.
Patent CA-2629228-A1 (CA)
Title: Pyrrolopyridines as kinase inhibitors
Inventor: VANOTTI ERMES
IPC: C07D471/04
Filed: 2006-11-08
Abstract: The present invention is directed to compounds of the formula (I) or pharmaceutically acceptable salts, prodrug, solvate or optical isomer thereof, pharmaceutical compositions containing same and use thereof for treating diseases linked to disreguiated cell proliferation or to disregutated protein kinase.
Patent CA-2630528-A1 (CA)
Inventor: SWENSON JON
IPC: A61M5/00
Filed: 2006-12-04
Abstract: A cutting element for a retracting needle syringe having a plunger with a cuttable distal end and a spring biased needle held by a cuttable support and a cutting element capable of cutting the cuttable distal end and the cuttable support includes a body portion having a proximal end, a distal end side wall therebetween and a passageway therethrough. The distal end of the body portion includes a cutting edge and a raised distally projecting tapered cutting tooth having distally converging edges. At least one tooth edge includes a sharp side wall for cutting the distal end of the plunger and the needle support.
Patent CA-2630746-A1 (CA)
Inventor: KNODEL BRYAN D
IPC: A61B17/04
Filed: 2006-11-22
Abstract: A polymeric, surgical clip having first and second curved legs with each having a pair of opposing side surfaces joined at their proximal ends by a flexible hinge section and movable from an open position to a closed position for clamping a vessel between curved opposing inner surfaces. The first leg terminates at its distal end in a female locking member, and the second leg member terminates in a male locking member complimentary to the female locking member such that when the first and second leg members are moved from an open position to a closed position about the hinge section the male member is lockingly engaged in the female locking member. The clip is provided with low profile boss-like elements on the legs thereof to reduce the risk of snapping a suture during coronary artery bypass graft surgery.
Patent CA-2632476-A1 (CA)
Title: Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
Inventor: BERMAN JUDD M
IPC: C07D471/14
Filed: 2006-12-01
Abstract: In part, the present invention is directed towards compounds with FabI  inhibiting properties. Such compounds may also inhibit other enzymes, including those similar to FabI either structurally or functionally, for example, Fab K. Kits and compositions that include the disclosed compounds are also provided. Methods of treating a subject with a bacterial illness is also disclosed.
Patent CA-2637461-A1 (CA)
Inventor: BASKIN BRYAN K
IPC: B64C27/12
Filed: 2006-02-24
Abstract: A rotor yoke includes a blade attachment portion, a mast attachment portion, and an intermediate portion extending between the blade attachment portion and the mast attachment portion. The intermediate portion, the blade attachment portion, and the mast attachment portion define an optional inner edge, such that the inner edge, if present, defines an opening. The rotor yoke further includes a peripheral, outer edge extending about the blade attachment portion, the intermediate portion, and the mast attachment portion. At least one of the outer edge and the inner edge, if present, includes a reduced thickness portion exhibiting a thickness that is less than a thickness of an adjacent portion of the rotor yoke.
Patent CA-2638752-A1 (CA)
Title: Handheld mobile communication device with repositionable display and inputs
Inventor: GRIFFIN JASON T
IPC: H04M1/7243
Filed: 2002-10-16
Abstract: A digital communications device with a reduced size, enhanced keyboard and large screen is disclosed. The mobile device has an auxiliary input such as a keyboard with a plurality of keys that is arranged in a first position to minimize the size of the device, and in a second position to enable the use of the auxiliary input in conjunction with other auxiliary inputs and the display. When in the first position, the keyboard is used to make telephone inputs and when in the second position, the keyboard is used to make textual inputs.
Patent CA-2641820-A1 (CA)
Inventor: HOOD PETER DAVID
IPC: F16J15/10
Filed: 2007-02-01
Abstract: A gasket formed of compressible material and having a first sealing surface and a second sealing surface for providing a fluid seal between a first component and a second component, a plurality of cavities provided within the gasket proximate the first and/or second sealing surfaces and extending over at least a first portion of the gasket to provide increased compressibility of the gasket in the first portion.
Patent CA-2642583-A1 (CA)
Title: Boron-containing small molecules as anti-inflammatory agents
Inventor: FREUND YVONNE
IPC: A01N55/08
Filed: 2007-02-16
Abstract: Use for treating anti-inflammatory conditions of boron-containing small molecules of formula Ia are disclosed: (see formula IA)
Patent CA-2646546-A1 (CA)
Title: A device, system and method for determining the effect of photodynamic or photothermal tumor therapy
Inventor: SVANBERG SUNE
IPC: A61B5/026
Filed: 2006-05-12
Abstract: A device and method for determining the effect of therapy in a tumour tissue of a human or a mammal under interstitial photodynamic or photothermal therapy by analyzing a liquid flow in a tissue of a human or a mammal. A first fibre is interstitially inserted in a first position of said tissue and connected to a light source, and a second fibre is interstitially inserted in a second position of said tissue for receiving light emitted from the first fibre. A detector is arranged for receiving the light from said second fibre for producing an output signal. An analysator receives the output signal from the detector and determines if there is a frequency component in the frequency area below about 1 MHz in the output signal, which is indicative of blood cell movement in the tissue. If the frequency component is below a threshold value, it is determined that there is no blood flow. In photothermal therapy, no blood flow is interpreted as the fact that the blood has coagulated and the therapy may be finalized. In photodynamic tumour therapy, changes in blood flow may be used to evaluate the treatment progression.
Patent CA-2646612-A1 (CA)
Title: Dosage aerosols for the administration of pharmaceutical preparations
Inventor: ROHRSCHNEIDER MARC
IPC: A61M15/00
Filed: 2007-03-26
Abstract: The invention relates to a device for providing pharmaceutical active ingredients, active ingredient mixtures and active ingredient formulations for use as aerosol in propellant-containing [1,1,1,2-tetrafluorethane (HFC-134a) or 1,1,2,3,3,3-heptafluoropropane (HFC-227)] dosage aerosols. The invention also relates to the dosage aerosols for applying said active ingredients, active ingredient mixtures and active ingredient formulations.
Patent CA-2647472-A1 (CA)
Title: Organic compounds
Inventor: VEDANANDA THALATHTHANI RALALAGE
IPC: C07D417/10
Filed: 2007-03-29
Abstract: Compounds of the formula (I) are inhibitors of protein tyrosine phosphatases (PTPases) and, thus, may be employed for the treatment of conditions mediated by PTPase activity. The compounds of the present invention may also be employed as inhibitors of other enzymes characterized with a phosphotyrosine binding region such as the SH2 domain Accordingly, the compounds of formula (I) may be employed for prevention and/or treatment of insulin resistance associated with obesity, glucose intolerance, diabetes mellitus, hypertension and ischemic diseases of the large and small blood vessels, conditions that accompany type-2 diabetes, including hyperlipidemia, hypertriglyceridemia, atherosclerosis, vascular restenosis, irritable bowel syndrome, pancreatitis, adipose cell tumors and carcinomas such as liposarcoma, dyslipidemia, and other disorders where insulin resistance is indicated. In addition, the compounds of the present invention may be employed to treat and/or prevent cancer, osteoporosis, musculoskeletal, neurodegenerative and infectious diseases, and diseases involving inflammation and the immune system.
Patent CA-2650149-A1 (CA)
Inventor: MUJKIC ALEN
IPC: G06Q10/00
Filed: 2009-01-16
Abstract: A portable electronic device method of determining time periods for a meeting includes receiving an indication of at least two invitees for the meeting, obtaining calendar data for the invitees, determining free time periods for the invitees based on the calendar data, and creating a list of the free time periods for the invitees.
Patent CA-2650951-A1 (CA)
Title: Seam construction for a woven fabric
Inventor: BECKER MICHAEL
IPC: D03D1/02
Filed: 2007-05-07
Abstract: Seam construction for a woven fabric for an OPW airbag, in particular for person restraint systems, which seam construction is characterized by a wea ving seam (Ia) having a single-layer region which is surrounded by an at lea st two-layer region (6), the individual layers of which have in each case a looser woven structure than the single-layer region.
Patent CA-2651629-A1 (CA)
Title: Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
Inventor: BROWN MATTHEW FRANK
IPC: A61P25/00
Filed: 2007-04-26
Abstract: The invention relates to compounds of formula (I) and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof; wherein B, D, E, R1, R2, R3, R4, R5, R8, m, n, p, q, r, s, t and u are as defined herein. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimmune diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
Patent CA-2656550-A1 (CA)
Inventor: MIDDLESWORTH JEFFREY ALAN
IPC: B32B3/30
Filed: 2007-06-29
Abstract: [A stretchable embossed elastic laminate including at least one nonwoven fabric layer, and at least one elastomeric material extruded as a melt onto a major surface of the nonwoven fabric to form an elastic layer bonded to the surface of the nonwoven fabric. The elastic laminate is embossed with a deep embossing pattern to provide an embossed laminate having good tensile strength and excellent resistance to delamination. Also disclosed is a method of forming a stretchable embossed laminate wherein at least one melted elastic material is extruded onto a major surface of the nonwoven fabric, and the elastic material and the nonwoven fabric are conveyed through a nip formed by a layon roll and an embossing roll having a deep embossing pattern.
Patent CA-2659232-A1 (CA)
Title: Latex processes
Inventor: LAI ZHEN
IPC: C08G63/78
Filed: 2009-03-20
Abstract: Processes for continuously forming latex emulsions useful in preparing toners are provided which do not require the use of solvents.
Patent CA-2659656-A1 (CA)
Inventor: CARMELIET PETER
IPC: C12Q1/68
Filed: 2001-04-12
Abstract: The present invention relates to neurological and physiological dysfunction associated with neuron disorders. In particular, the invention relates to the involvement of vascular endothelial growth factor (VEGF) and homologues in the aetiology of motor neuron disorders. The invention further concerns a novel, mutant transgenic mouse (VEGF m/m) with a homozygous deletion in the hypoxia responsive element (HRE) of the VEGF    promoter which alters the hypoxic upregulation of VEGF. These mice suffer severe adult onset muscle weakness due to progressive spinal motor neuron degeneration which is reminiscent of amyotrophic lateral sclerosis (ALS) - a fatal disorder with unknown aetiology. Furthermore, the neuropathy of these mice is not caused by vascular defects, but is due to defective VEGF-mediated survival signals to motor neurons. The present invention relates in particular to the isoform VEGF165 which stimulates survival of motor neurons via binding to neuropilin-1, a receptor known to bind semaphorin-3A  which is implicated in axon retraction and neuronal death, and the VEGF Receptor-2. The present invention thus relates to the usage of VEGF, in particular VEGF165, for the treatment of neuron disorders and relates, in addition, to the usage of polymorphisms in the VEGF  promotor for diagnosing the latter disorders.
Patent CA-2659741-A1 (CA)
Title: Device for espresso-like infusions
Inventor: RAPPARINI GINO
IPC: A47J31/44
Filed: 2007-07-12
Abstract: A device for espresso-like infusions characterized by a structure (S) provided with programmable mechanisms to heat up, distribute and inject water into the infusion process, and equipped with a triplet of operating elements (1, 2, 3).
Patent CA-2659916-A1 (CA)
Inventor: COLLINS DOUGLAS P
IPC: E06B3/30
Filed: 2009-03-24
Abstract: Embodiments of door protectors are described. One typical embodiment comprises front and rear corrugated cardboard panels that are draped over a door by way of one or more pieces of saddle tape that join the panels along their respective top edges. A plurality of folds, perforations and cutouts are provided on the faces of the panels to permit access to the door's hardware. Accordingly, the door can be operated in a traditional manner while providing impact and damage protection to the door. The panels include a plurality of widthwise folds that permit the door protector to be folded for transport and storage. In variations, the edge straps are provided often comprised of hook and loop material to both secure the protector in a folded configuration and to an associated door.
Patent CA-2661278-A1 (CA)
Inventor: SWYSGOOD MATTHEW S
IPC: B21D11/10
Filed: 2009-04-03
Abstract: A vibration isolating mounting clip which is used to mount a furring channel to a mounting surface, which is then further loaded with a finishing substrate via the furring channel consists of a resilient bent metal strip.  The resilient bent metal strip has a first end and an opposing second end, and a transition portion shaped to fit the furring channel. Through different aspects of the invention either the first end, or the first and second end is mounted to the mounting surface. The resilient bent metal strip has a stiffness and shape such that when the furring channel is positioned in the resilient bent metal strip, and the resilient bent metal strip is mounted to the mounting surface, and a finishing substrate is loaded on the furring channel, the furring channel does not contact the mounting surface. Between the ends of the resilient bent metal strip, and the furring channel, are one to several bends, towards and away from the mounting surface to achieve the desired resiliency.
Patent CA-2663010-A1 (CA)
Title: Unitary cosmetic compact with decoupled motion
Inventor: CORBELLINI FRANCIS
IPC: A45D40/00
Filed: 2007-09-20
Abstract: A cosmetic compact of increased stability, comprising a base, a cosmetic article carrier disposed within the base and a cap. With respect to the base, the cap is sometimes capable of translation and sometimes capable of rotation, but the cap can only perform one type of motion at a time, depending on the relative orientation of the cap and base. There is one orientation of the cap with respect to the base from which a user may execute either translation or rotation, but not simultaneously. A selective rotation mechanism decouples translational motion of the cap from rotational motion. Thus, compound movement of the cap, with respect to the base, is not possible. Translation of the cap with respect to the base causes translation of the article carrier. Inadvertent movement of the carrier is eliminated, because when the device is in an orientation for use, translation of the carrier is prohibited.